Skip to content

    Akebia Therapeutics (AKBA) stock price & financials

    View AKBA earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance70.8% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $37.43M
    $46.50M
    $57.34M
    $62.47M
    $58.77M
    +57.0%
    $57.62M
    +23.9%
    $53.54M
    -6.6%
    $49.13M
    -21.4%
    Stable
    Operating Profit
    -$12.51M
    -$14.31M
    $13.51M
    $14.09M
    $4.45M
    -$8.55M
    +40.2%
    -$4.70M
    -134.7%
    -$6.33M
    -144.9%
    Weakening
    Net Profit
    -$20.04M
    -$22.80M
    $6.11M
    $247.0K
    $540.0K
    -$12.24M
    +46.3%
    -$9.05M
    -248.1%
    -$8.91M
    -3706.5%
    Weakening
    EPS
    $-0.10
    $0.03
    $0.00
    $0.00
    +100.0%
    $-0.03
    -200.0%
    $-0.03
    Weakening
    Other Income
    Interest
    Depreciation
    Profit before Tax
    -$20.04M
    -$22.80M
    $6.11M
    $247.0K
    $1.16M
    -$11.23M
    +50.7%
    -$8.93M
    -246.1%
    -$8.84M
    -3678.1%
    Weakening
    MarginsOPM
    -33.4%
    -30.8%
    23.6%
    22.6%
    7.6%
    -14.8%
    +51.8%
    -8.8%
    -137.2%
    -12.9%
    -157.1%
    Weakening
    Tax
    0.0%
    0.0%
    0.0%
    53.3%
    -9.0%
    -1.4%
    -0.8%
    Weakening
    ReturnsROIC
    1.2%
    1.3%
    -0.4%
    -0.0%
    -0.0%
    -102.7%
    0.7%
    -46.3%
    0.5%
    0.5%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$104.64M$147.45M$228.70M$149.80M$90.47M$42.92M$51.87M$184.84M$155.55M
    Short-Term Investments
    Total Current Assets$468.27M$309.53M$371.44M$271.15M$185.18M$118.15M$113.83M$252.96M$229.55M
    Net PP&E$8.02M$39.42M$35.50M$40.61M$34.37M$16.05M$10.42M$4.88M$7.31M
    Goodwill$55.05M$55.05M$55.05M$59.04M$59.04M$59.04M$59.04M$59.04M$59.04M
    Intangibles$328.15M$291.21M$144.17M$108.13M$72.08M$36.04M$0
    Total Assets$996.54M$771.20M$644.14M$529.35M$356.05M$241.70M$220.67M$376.56M$349.66M
    LiabilitiesTotal Current Liabilities$265.69M$208.12M$187.15M$261.05M$129.54M$99.87M$80.91M$162.94M$160.87M
    Short-Term Debt$15.00M$0$97.54M$32.00M$17.50M$0$0$24.81M
    Long-Term Debt$75.81M$96.38M$0$34.08M$17.18M$38.69M$48.25M$24.75M
    Long-Term Leases$27.53M$24.62M$33.70M$28.96M$8.95M$3.55M$0$4.40M
    Total Liabilities$360.61M$376.44M$396.52M$455.34M$350.82M$272.29M$269.86M$343.95M$324.64M
    EquityCommon Stock & APIC$1.0K$1.0K$1.0K$1.0K$2.0K$2.0K$2.0K$2.0K$2.0K
    Retained Earnings-$514.39M-$794.05M-$1.18B-$1.46B-$1.56B-$1.61B-$1.68B-$1.68B-$1.70B
    Total Equity$635.93M$392.88M$244.35M$74.01M$5.23M-$30.58M-$49.19M$32.61M$25.02M
    HighlightsNet Cash / (Debt)$132.32M$52.26M$24.39M$8.24M$13.18M$136.59M$105.98M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$97.49M-$257.44M-$110.39M-$252.97M-$73.15M-$23.38M-$40.66M$67.99M$41.55M
    Cash from Investing$36.59M$211.18M-$40.00M$39.94M-$114.0K$0-$33.0K-$7.93M-$12.10M
    Cash from Financing$96.56M$88.97M$231.72M$133.73M$14.60M-$25.21M$49.66M$72.93M-$11.20M
    SummaryCapital Expenditure-$1.61M-$6.66M-$317.0K-$59.0K-$114.0K$0-$33.0K-$291.0K-$1.29M
    Free Cash Flow-$99.10M-$264.10M-$110.70M-$253.02M-$73.27M-$23.38M-$40.69M$67.70M$40.26M
    FCF Margin-47.7%-78.8%-37.6%-119.5%-25.1%-12.0%-25.4%28.7%18.4%

    Ratios